#United States #Boehringer Ingelheim #Johns Creek #Animal Health

Boehringer Ingelheim Celebrates New Headquarters Opening

Boehringer Ingelheim, the renowned biopharmaceutical company, recently held the grand opening of its new U.S. headquarters for Animal Health in Johns Creek, Georgia. This significant event exemplifies the company's devotion to boosting innovation, attracting talent, and shaping the future landscape of animal health. The choice of Johns Creek as the location reflects its strategic advantage, being situated in a rapidly expanding life sciences and innovation hub while remaining close to other vital Boehringer properties across Georgia.

During the celebration, a diverse group of attendees including local elected officials, influential community leaders, customers, and Boehringer employees gathered to witness the unveiling of this new facility. The sentiments expressed during the event strongly resonated with the company's mission of transforming lives through scientific advancements.

Peter Ploeger, the U.S. Animal Health Country Managing Director, emphasized that the needs of the animals they serve and their owners are paramount. He stated, "Our headquarters is designed to foster collaboration, inspire innovation, and enhance our capability to develop solutions that improve the welfare of both companion animals and livestock, alongside those entrusted to care for them. We're excited to make Johns Creek our home and look forward to the positive impact we can achieve together."

The new headquarters is part of a broader footprint that Boehringer maintains in Georgia, which also encompasses research, development, and manufacturing facilities in Athens, as well as additional manufacturing operations in Gainesville. The integration of these locations underlines the critical role the U.S. market plays in the company's overall strategy. As Dr. Armin Wiesler, an executive board member in the animal health segment, highlighted during the festivities, the company continues to commit to advancing animal health solutions globally, reflecting an unwavering investment into operations within Georgia.

Georgia's leadership, including Governor Brian P. Kemp, noted that the state has become a magnet for leading enterprises, thanks to its skilled workforce and favorable business conditions. Governor Kemp also recognized Boehringer Ingelheim's investment in the local community, elaborating on the company's support for various initiatives, including those geared towards animal welfare and K-9 law enforcement.

As a token of this commitment, a special presentation was held where Alexandra McMenamy, Head of Pet at Boehringer, joined local officials to donate NexGard® Plus to the Johns Creek Police Department's K-9 Unit. This gesture coinciding with International Dog Day serves to highlight the company's dedication not only to animal health but also to supporting local community initiatives.

John Bradberry, the Mayor of Johns Creek, expressed his gratitude, stating, "We are honored to welcome a company like Boehringer Ingelheim to our community, particularly one that is so passionate about the welfare of animals." The contribution towards the K-9 Unit showcases their acknowledgment of safety and health in the community.

Boehringer Ingelheim has made a name for itself as a leader in the biopharmaceutical industry, focusing on both human and animal health. With a substantial commitment to research and development, the company relentlessly pursues innovative therapies catering to unmet medical needs. Since its founding in 1885, Boehringer has operated as an independent entity, fundamentally integrating sustainability into every aspect of its operations. Currently, with more than 54,500 employees, the company serves over 130 markets worldwide, striving for a healthier and more sustainable future.

For further insights into Boehringer Ingelheim's initiatives and offerings, please visit Boehringer Ingelheim Animal Health.